Results 161 to 170 of about 16,156 (211)

Mupirocin resistance

Lancet, The, 1991
R, Wise, J, Johnson
exaly   +3 more sources

Mupirocin resistance

Lancet, The, 1992
BruceH. Thiers, I. Hudson, Richard Wise, H. Rode, P.M. De Wet, A.J.W. Millar, S. Cywes   +6 more
exaly   +4 more sources

Mupirocin-resistant Staphylococcus aureus

Lancet, The, 1990
B D, Cookson, R W, Lacey, W C, Noble, D S, Reeves, R, Wise, R J, Redhead   +5 more
exaly   +3 more sources

Failure of mupirocin-resistant staphylococci to inactivate mupirocin

European Journal of Clinical Microbiology & Infectious Diseases, 1989
Isolates from four UK centres, comprising four Staphylococcus aureus strains and one Staphylococcus epidermidis strain with high-level mupirocin resistance, and one strain each of Staphylococcus aureus and Staphylococcus epidermidis with low-level mupirocin resistance, were assessed for intracellular or extracellular enzymatic alteration of the ...
openaire   +2 more sources

Mupirocin: applications and production

Biotechnology Letters, 2019
Mupirocin is an antibiotic from monocarboxylic acid class used as antibacterial agent against methicillin-resistant Staphylococcus aureus (MRSA) and can be obtained as a mixture of four pseudomonic acids by Pseudomonas fluorescens biosynthesis. Nowadays improving antibiotics occupies an important place in the pharmaceutical industry as more and more ...
Alexandra Tucaliuc, Alexandra Cristina Blaga, Anca Irina Galaction, Dan Cascaval   +3 more
openaire   +2 more sources

Mupirocin resistance is not an inevitable consequence of mupirocin use

Journal of Hospital Infection, 2011
The rate of mupirocin resistance in meticillin-resistant Staphylococcus aureus (MRSA) in Besançon University Hospital is low with a decreasing trend, from 10% in 2004 to 3% in 2009. This trend in resistance paralleled mupirocin consumption. Genotyping results showed that this decrease was not linked to a change in MRSA clones.
Talon, D., Marion, C., Thouverez, M., Bertrand, X.   +3 more
openaire   +3 more sources

Nano-mupirocin: enabling the parenteral activity of mupirocin

European Journal of Nanomedicine, 2016
Abstract Mupirocin is an antibiotic having a unique mode of action, not shared by any other therapeutically available antibiotic. However, due to its rapid elimination following injection and high protein binding, current therapeutic use is limited to topical administration.
Ahuva Cern, Ayelet Michael-Gayego, Yaelle Bavli, Erez Koren, Amiram Goldblum, Allon E. Moses, Yan Q. Xiong, Yechezkel Barenholz   +7 more
openaire   +1 more source